Covid-19 | Page 80 of 100 | Links Medicus Content Curation & Alerts in Medicine

WHO chief – The world can bring the global COVID-19 pandemic under control in the coming months provided it distributes the necessary resources fairly

25 Apr, 2021 | 22:08h | UTC

The world can bring the global COVID-19 pandemic under control in the coming months provided it distributes the necessary resources fairly – Reuters

Commentary on Twitter

We have all the tools to tame the #COVID19 pandemic everywhere in a matter of months. It comes down to a simple choice: to share or not to share. My piece on #VaccinEquity in the @nytimes. https://t.co/OIRAogZPwl

— Tedros Adhanom Ghebreyesus (@DrTedros) April 23, 2021

Recommendations to address patients fear of adverse effects and COVID-19 vaccine hesitancy

25 Apr, 2021 | 21:58h | UTC

Fear of Adverse Effects and COVID-19 Vaccine Hesitancy: Recommendations of the Treatment Expectation Expert Group – JAMA Health Forum

WHO: COVID-19 continues to disrupt essential health services in 90% of countries

25 Apr, 2021 | 22:12h | UTC

COVID-19 continues to disrupt essential health services in 90% of countries – World Health Organization

Commentary on Twitter (thread – click for more)

Over one year into the #COVID19 pandemic, about 9⃣0⃣% of countries surveyed still report one or more disruptions to essential health services. Major efforts are required to restore and strengthen services in all countries.

👉 https://t.co/P34xPKY1Io pic.twitter.com/UYDQPX67Vw

— World Health Organization (WHO) (@WHO) April 23, 2021

U.S. lifts pause on use of J&J’s Covid-19 vaccine

25 Apr, 2021 | 21:57h | UTC

U.S. lifts pause on use of J&J’s Covid-19 vaccine – STAT

One million coronavirus sequences: popular genome site hits mega milestone

25 Apr, 2021 | 21:59h | UTC

One million coronavirus sequences: popular genome site hits mega milestone – Nature

Resurgence of SARS-CoV-2: detection by community viral surveillance

25 Apr, 2021 | 21:55h | UTC

Resurgence of SARS-CoV-2: detection by community viral surveillance – Science

Commentary on Twitter

A #SARSCoV2 surveillance program tested in England in 2020 successfully detected a resurgence of virus infection at low prevalence, @imperialcollege researchers say. Such programs can augment routine surveillance to inform public health interventions. https://t.co/veilAJ8YX4 pic.twitter.com/9YFQbvtqbw

— Science Magazine (@ScienceMagazine) April 23, 2021

Long Covid: Largest post-acute COVID-19 study to date examined the health outcomes in more than 73,000 people who’d had COVID-19 and were not hospitalized

23 Apr, 2021 | 08:48h | UTC

High-dimensional characterization of post-acute sequalae of COVID-19 – Nature

Commentary: Among COVID-19 survivors, an increased risk of death, serious illness – Washington University School of Medicine

Commentary on Twitter (thread – click for more)

Happy to share the latest paper from our team in @nature

A comprehensive characterization of post acute sequelae of COVID-19#longcovid #PASC https://t.co/AGLnYCamWe @VAResearch @vahsrd @WUSTL @WUSTLpubhealth @WUSTLmed @WUSTLnews @VREFSTL @Biostayan @BCBowe

— Ziyad Al-Aly, MD (@zalaly) April 22, 2021

NIH Updates COVID-19 Treatment Guidelines – adds recommendations on colchicine, fluvoxamine, and monoclonal antibodies

23 Apr, 2021 | 08:46h | UTC

NIH Coronavirus Disease 2019 (COVID-19)
Treatment Guidelines – National Institutes of Health

RCT: COVID outpatients don’t benefit from hydroxychloroquine, lopinavir-ritonavir

23 Apr, 2021 | 08:42h | UTC

COVID outpatients don’t benefit from hydroxychloroquine, lopinavir-ritonavir – CIDRAP

Original study: Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial – JAMA Network Open

Commentary on Twitter (thread – Click for more)

1/ No benefit from Hydroxychloroquine or Lopinavir-Ritonavir on Hospitalization/Viral clearance for COVID-19 https://t.co/yhXxv26418 via @JAMANetworkOpen part of @JAMANetwork

— Priya Sampathkumar (@PSampathkumarMD) April 22, 2021

Case series of 18 male adults aged 50 years or younger with acute ischemic stroke during the convalescent phase of asymptomatic Covid-19

23 Apr, 2021 | 08:39h | UTC

Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men – JAMA Network Open

Commentary: ‘The next wave of complications’: Asymptomatic COVID-19 patients face a prolonged stroke risk – Cardiovascular Business

Commentary on Twitter

A 💥🆕 case series highlights that adults 50 years or younger with asymptomatic COVID-19 infection diagnosed by positive SARS-CoV-2 serological test result may present with ischemic stroke during the convalescent phase of the infection
https://t.co/BVlo7Z1hgn @JAMANetworkOpen

— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) April 22, 2021

Covid-19: More data on the increased risks to pregnant women and their newborn infants

23 Apr, 2021 | 08:44h | UTC

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study – JAMA Pediatrics

Editorial: COVID-19 in Pregnant Women and Their Newborn Infants

Commentaries: Pregnant women with COVID-19 face high mortality rate – University of Washington School of Medicine AND Covid-19 raises risks for expectant mothers and babies, study says – CNN

Commentary on Twitter

18 country study in >2000 pregnant women with and without #COVID19 shows higher complication and death rates in symptomatic, but not asymptomatic, women with COVID-19. Their babies were at greater risk of neonatal complications, mainly due to preterm birth https://t.co/mRl8OOIMsz

— JAMA Pediatrics (@JAMAPediatrics) April 22, 2021

RCT: Single-Dose Johnson & Johnson Vaccine has 85% efficacy against severe/critical Covid-19 and maintains efficacy against variant B.1.351

22 Apr, 2021 | 08:50h | UTC

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 – New England Journal of Medicine

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

22 Apr, 2021 | 08:49h | UTC

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons – New England Journal of Medicine

Audio Interview: Covid-19 Vaccines and Pregnancy — A Conversation with CDC Director Rochelle Walensky – New England Journal of Medicine

Commentaries: No evidence that Pfizer or Moderna vaccines are unsafe during pregnancy, a preliminary study says. – The New York Times AND Preliminary data show no safety concerns for pregnant women receiving COVID-19 vaccines – AAP News AND Messenger RNA COVID vaccines likely safe for pregnant women: Study – ABC News

Covid-19: What do we know about airborne transmission of SARS-CoV-2?

23 Apr, 2021 | 08:33h | UTC

Covid-19: What do we know about airborne transmission of SARS-CoV-2? – The BMJ

COVID vaccines and kids: five questions as trials begin

23 Apr, 2021 | 08:37h | UTC

COVID vaccines and kids: five questions as trials begin – Nature

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

22 Apr, 2021 | 08:47h | UTC

Vaccine Breakthrough Infections with SARS-CoV-2 Variants – New England Journal of Medicine

Commentary on Twitter

Mild #COVID19 symptoms developed in two fully vaccinated persons. Serum tests showed high titers of antibodies capable of neutralizing the wild-type strain of #SARSCoV2 first identified in Wuhan, China, but sequencing of the virus isolates revealed novel variants.

— NEJM (@NEJM) April 21, 2021

Opinion | Platform Trials — Beware the Noncomparable Control Group

22 Apr, 2021 | 08:44h | UTC

Platform Trials — Beware the Noncomparable Control Group – New England Journal of Medicine

A year in the COVID-19 vaccine scheme COVAX

22 Apr, 2021 | 08:43h | UTC

A year in the COVID-19 vaccine scheme COVAX – Reuters

Study shows low incidence of post-acute COVID-19 symptoms (“Long Covid”) in children after mild disease

22 Apr, 2021 | 08:40h | UTC

Post-acute COVID-19 outcomes in children with mild and asymptomatic disease – The Lancet Child & Adolescent Health

Commentaries on Twitter

Early data from @RCHMelbourne show that, at 3-6 month follow-up, all 151 children with mild and asymptomatic #COVID19 had returned to their baseline health status and post-acute COVID-19 symptoms had resolved.

Letter from @Shidan_Tosif & colleagues: https://t.co/XXa0EPIgPY

— The Lancet Child & Adolescent Health (@LancetChildAdol) April 20, 2021

Given such little available data, this study from Australia on post-acute COVID-19 symptoms in children is very important

Findings are extremely reassuring

Post-acute symptoms were rare, and mild (cough 4%, fatigue 2%, cough and fatigue 1%)

Great news!https://t.co/TEJyES3Crx

— Alasdair Munro (@apsmunro) April 21, 2021

Great to see research looking at whether long Covid is a problem in children.

From this Melbourne cohort, enduring cough and fatigue are uncommon.

It hasn’t been clear to me whether borders will reopen before children are vaccinated so this is VIP https://t.co/iLXqwXJmOt

— Jin Russell (@DrJinRussell) April 21, 2021

Truly encouraging data on post-acute #COVID19 in children. Single-center in Australia. n=151.
8% post-acute symptoms – all symptomatic COVID-19.
Mild symptoms: cough 4%, fatigue 2%, both 1%. Duration: cough 3-8w; post-viral fatigue 6-8w. All solved in follow-up time 3-6 months. https://t.co/vKrEFZlw3C

— Pablo Guisado Vasco (@PabloGVasco) April 21, 2021

Perspective | Do Kids Really Need to Be Vaccinated for Covid? Yes. No. Maybe.

22 Apr, 2021 | 08:38h | UTC

Do Kids Really Need to Be Vaccinated for Covid? Yes. No. Maybe. – Undark

Commentary on Twitter

Great article by @Sara_Talpos
key qs:
1 Does a kid need to be vaccinated for their sake?
2 Does a kid need to be vaccinated to protect adults who decline?
3. Does a kid need to be vaccinated to protect adults who were vax'd?

1/2https://t.co/6WpbttIiDo

— Vinay Prasad MD MPH (@VPrasadMDMPH) April 20, 2021